Select Committee on Health Innovation Florida House of Representatives 214 House Office Building, 402 South Monroe Street Tallahassee, Florida 32399 Dear Representative, On behalf of the 20,852 members and supporters of the Council for Citizens Against Government Waste (CCAGW) in Florida, I urge you to oppose HB1431, which will implement an international drug pricing model that […]
CAGW has long been concerned with the misuse of the 340B Program.
A new study, “The 340B Drug Discount Program Exceeds $100B in 2022,” shows the program is misused.
A new study, “340B and Health Equity: A Missed Opportunity in Medically Underserved Areas,” shows the program is misused.
Sen. Ron Wyden (D-Ore.) wants to use price controls in Medicare Part D to pay for President Biden’s extravagant spending.
The Biden administration’s budget includes new enforcement tools for oversight of the 340B program but the details will matter.
Berkeley Research Group report shows once again how 340B has been corrupted and is being abused.
President Trump signs controversial Executive Order (EO) implementing “most favored nation” policy to lower drug costs.
Amid the COVID-19 pandemic response, the 340B drug safety-net program problems seem to have gotten lost.
Patients receiving hospital care don’t know if they will get stuck with enormous and unexpected bills when they are released.
